These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 22863765)

  • 1. Lymphotoxin β receptor signaling promotes development of autoimmune pancreatitis.
    Seleznik GM; Reding T; Romrig F; Saito Y; Mildner A; Segerer S; Sun LK; Regenass S; Lech M; Anders HJ; McHugh D; Kumagi T; Hiasa Y; Lackner C; Haybaeck J; Angst E; Perren A; Balmer ML; Slack E; MacPherson A; Manz MG; Weber A; Browning JL; Arkan MC; Rülicke T; Aguzzi A; Prinz M; Graf R; Heikenwalder M
    Gastroenterology; 2012 Nov; 143(5):1361-1374. PubMed ID: 22863765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of lymphotoxin signaling in the development of autoimmune pancreatitis and associated secondary extra-pancreatic pathologies.
    Seleznik GM; Zoller J; O'Connor T; Graf R; Heikenwalder M
    Cytokine Growth Factor Rev; 2014 Apr; 25(2):125-37. PubMed ID: 24508087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A lymphotoxin-driven pathway to hepatocellular carcinoma.
    Haybaeck J; Zeller N; Wolf MJ; Weber A; Wagner U; Kurrer MO; Bremer J; Iezzi G; Graf R; Clavien PA; Thimme R; Blum H; Nedospasov SA; Zatloukal K; Ramzan M; Ciesek S; Pietschmann T; Marche PN; Karin M; Kopf M; Browning JL; Aguzzi A; Heikenwalder M
    Cancer Cell; 2009 Oct; 16(4):295-308. PubMed ID: 19800575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The lymphotoxin β receptor is a potential therapeutic target in renal inflammation.
    Seleznik G; Seeger H; Bauer J; Fu K; Czerkowicz J; Papandile A; Poreci U; Rabah D; Ranger A; Cohen CD; Lindenmeyer M; Chen J; Edenhofer I; Anders HJ; Lech M; Wüthrich RP; Ruddle NH; Moeller MJ; Kozakowski N; Regele H; Browning JL; Heikenwalder M; Segerer S
    Kidney Int; 2016 Jan; 89(1):113-26. PubMed ID: 26398497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of autoimmune pancreatitis is independent of CDKN1A/p21-mediated pancreatic inflammation.
    Seleznik GM; Reding T; Peter L; Gupta A; Steiner SG; Sonda S; Verbeke CS; Dejardin E; Khatkov I; Segerer S; Heikenwalder M; Graf R
    Gut; 2018 Sep; 67(9):1663-1673. PubMed ID: 28774888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amelioration of Murine Autoimmune Pancreatitis by Targeted LTβR Inhibition and Anti-CD20 Treatment.
    Wanner-Seleznik GM; Reding T; Chen R; Gupta AK; Lenggenhager D; Browning J; Segerer S; Heikenwalder M; Graf R
    Immunohorizons; 2020 Nov; 4(11):688-700. PubMed ID: 33154038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of lymphotoxin-alpha in cigarette smoke-induced inflammation and lymphoid neogenesis.
    Demoor T; Bracke KR; Maes T; Vandooren B; Elewaut D; Pilette C; Joos GF; Brusselle GG
    Eur Respir J; 2009 Aug; 34(2):405-16. PubMed ID: 19164352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis of autoimmune pancreatitis.
    Matsubayashi H; Kakushima N; Takizawa K; Tanaka M; Imai K; Hotta K; Ono H
    World J Gastroenterol; 2014 Nov; 20(44):16559-69. PubMed ID: 25469024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphotoxin-β receptor activation by lymphotoxin-α(1)β(2) and LIGHT promotes tumor growth in an NFκB-dependent manner.
    Daller B; Müsch W; Röhrl J; Tumanov AV; Nedospasov SA; Männel DN; Schneider-Brachert W; Hehlgans T
    Int J Cancer; 2011 Mar; 128(6):1363-70. PubMed ID: 20473944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Remission and relapse of autoimmune pancreatitis: focusing on corticosteroid treatment.
    Kim HM; Chung MJ; Chung JB
    Pancreas; 2010 Jul; 39(5):555-60. PubMed ID: 20182397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of established experimental autoimmune encephalomyelitis and formation of meningeal lymphoid follicles by lymphotoxin beta receptor-Ig fusion protein.
    Columba-Cabezas S; Griguoli M; Rosicarelli B; Magliozzi R; Ria F; Serafini B; Aloisi F
    J Neuroimmunol; 2006 Oct; 179(1-2):76-86. PubMed ID: 16870269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemokines determine local lymphoneogenesis and a reduction of circulating CXCR4+ T and CCR7 B and T lymphocytes in thyroid autoimmune diseases.
    Armengol MP; Cardoso-Schmidt CB; Fernández M; Ferrer X; Pujol-Borrell R; Juan M
    J Immunol; 2003 Jun; 170(12):6320-8. PubMed ID: 12794165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Tumor Necrosis Factor Superfamily Members TNFSF14 (LIGHT), Lymphotoxin β and Lymphotoxin β Receptor Interact to Regulate Intestinal Inflammation.
    Giles DA; Zahner S; Krause P; Van Der Gracht E; Riffelmacher T; Morris V; Tumanov A; Kronenberg M
    Front Immunol; 2018; 9():2585. PubMed ID: 30524422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accelerated thymic atrophy as a result of elevated homeostatic expression of the genes encoded by the TNF/lymphotoxin cytokine locus.
    Liepinsh DJ; Kruglov AA; Galimov AR; Shakhov AN; Shebzukhov YV; Kuchmiy AA; Grivennikov SI; Tumanov AV; Drutskaya MS; Feigenbaum L; Kuprash DV; Nedospasov SA
    Eur J Immunol; 2009 Oct; 39(10):2906-15. PubMed ID: 19735075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blocking lymphotoxin beta receptor signalling exacerbates acute DSS-induced intestinal inflammation--opposite functions for surface lymphotoxin expressed by T and B lymphocytes.
    Jungbeck M; Stopfer P; Bataille F; Nedospasov SA; Männel DN; Hehlgans T
    Mol Immunol; 2008 Jan; 45(1):34-41. PubMed ID: 17590442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signal via lymphotoxin-beta R on bone marrow stromal cells is required for an early checkpoint of NK cell development.
    Wu Q; Sun Y; Wang J; Lin X; Wang Y; Pegg LE; Fütterer A; Pfeffer K; Fu YX
    J Immunol; 2001 Feb; 166(3):1684-9. PubMed ID: 11160211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphotoxin in the pathogenesis of autoimmune pancreatitis: a new player in the field.
    Algül H; Chari ST
    Gastroenterology; 2012 Nov; 143(5):1147-1150. PubMed ID: 23000229
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical significance of B cell-activating factor in autoimmune pancreatitis.
    Yamanishi H; Kumagi T; Yokota T; Azemoto N; Koizumi M; Kobayashi Y; Abe M; Murakami H; Hiasa Y; Matsuura B; Kawamoto H; Yamamoto K; Onji M
    Pancreas; 2011 Aug; 40(6):840-5. PubMed ID: 21747319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased production of immunoglobulin M and A in autoimmune pancreatitis.
    Taguchi M; Kihara Y; Nagashio Y; Yamamoto M; Otsuki M; Harada M
    J Gastroenterol; 2009; 44(11):1133-9. PubMed ID: 19626266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A lymphotoxin-IFN-beta axis essential for lymphocyte survival revealed during cytomegalovirus infection.
    Banks TA; Rickert S; Benedict CA; Ma L; Ko M; Meier J; Ha W; Schneider K; Granger SW; Turovskaya O; Elewaut D; Otero D; French AR; Henry SC; Hamilton JD; Scheu S; Pfeffer K; Ware CF
    J Immunol; 2005 Jun; 174(11):7217-25. PubMed ID: 15905567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.